Harry Burn
Sound Shore Management
Harry Burn Teva Pharma Industries Ltd ADR stake
total: 193
Sound Shore Management TEVA trades
- Total transactions:
- 11
- New positions:
- 1
- Added:
- 3
- Reduced:
- 7
- Held since:
- 2023 Q3
- Held for:
- 11 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Harry Burn holds 3,885,683 Teva Pharma Industries Ltd ADR (TEVA) shares with a market value of roughly $117.04M accounting for 3.92% of the overall portfolio. To date, the estimated cost basis is nearly $10.83 for "buy" trades and estimated average "sell" price is $21.49. Sound Shore Management first purchased TEVA in 2023 Q3, initially acquiring about 7.92M shares. Since the initial investment in Teva Pharma Industries Ltd ADR (TEVA), Sound Shore Management has made 10 more transactions.
When did Harry Burn buy Teva Pharma Industries Ltd ADR (TEVA)?
Harry Burn first invested in Teva Pharma Industries Ltd ADR (TEVA) in 2023 Q3 at the reported quarter-end price of $10.20 per share.
What's the cost basis of Sound Shore Management's TEVA stake?
The estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA) stake is around $10.83 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $10.83
- Weighted AVG sell price:
- $21.49
Harry Burn's historical trades in Teva Pharma Industries Ltd ADR
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
3.92%
|
3,885,683
|
$30.12
|
$117,036,772
|
-9.84% (-424,223)
|
-0.41%
|
|
2025 Q4
|
4.28%
|
4,309,906
|
$31.21
|
$134,512,166
|
-23.68% (-1,337,543)
|
-1.38%
|
|
2025 Q3
|
3.77%
|
5,647,449
|
$20.20
|
$114,078,470
|
-3.40% (-199,063)
|
-0.14%
|
|
2025 Q2
|
3.34%
|
5,846,512
|
$16.76
|
$97,987,541
|
+7.23% (+394,423)
|
+0.23%
|
|
2025 Q1
|
2.94%
|
5,452,089
|
$15.37
|
$83,798,608
|
+14.23% (+679,377)
|
+0.37%
|
|
2024 Q4
|
3.47%
|
4,772,712
|
$22.04
|
$105,190,573
|
-20.15% (-1,204,132)
|
-0.86%
|
|
2024 Q3
|
3.50%
|
5,976,844
|
$18.02
|
$107,702,728
|
-11.60% (-784,602)
|
-0.47%
|
|
2024 Q2
|
3.66%
|
6,761,446
|
$16.25
|
$109,873,498
|
-9.78% (-733,244)
|
-0.37%
|
|
2024 Q1
|
3.31%
|
7,494,690
|
$14.11
|
$105,750,076
|
-15.97% (-1,424,544)
|
-0.7%
|
|
2023 Q4
|
3.23%
|
8,919,234
|
$10.44
|
$93,116,803
|
+12.61% (+998,522)
|
+0.36%
|
|
2023 Q3
|
3.09%
|
$10.20
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.